Sitryx

Biotechnology company focused on immunometabolism, developing therapies

placeOxford, England, United Kingdom calendar_todayFounded 2018 groups17 employees language sitryx.com

Registered entities

Social engagement

Social engagement: 7K social following, 10 posts in the last 12 months — below the industry typical range.

Investor mix

7 investors on record; lead investors include SV Health Investors, Sofinnova Investments, Sofinnova Partners, Oxford Science Enterprises.

Investor typeCountShare
Venture capital571%
Other / undisclosed229%

Recent activity

22 Jun 2026
Milestone
regulatory
16 Jun 2026
Event
Biotechnology Innovation Organization International Convention
10 Jun 2026
Event
The Evolving Needs of R&D Panel Discussion
Coming soon